Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$28.82 - $77.35 $1.15 Million - $3.09 Million
-40,000 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$48.25 - $100.49 $723,750 - $1.51 Million
15,000 Added 60.0%
40,000 $2.65 Million
Q4 2021

Feb 08, 2022

BUY
$88.71 - $120.43 $2.22 Million - $3.01 Million
25,000 New
25,000 $2.5 Million
Q2 2021

Aug 10, 2021

SELL
$109.77 - $165.68 $1.1 Million - $1.66 Million
-10,000 Closed
0 $0
Q1 2021

May 12, 2021

SELL
$127.04 - $179.1 $4.45 Million - $6.27 Million
-35,000 Reduced 77.78%
10,000 $1.53 Million
Q4 2020

Feb 16, 2021

BUY
$99.96 - $135.93 $999,599 - $1.36 Million
10,000 Added 28.57%
45,000 $5.8 Million
Q3 2020

Nov 13, 2020

BUY
$80.32 - $111.8 $2.81 Million - $3.91 Million
35,000 New
35,000 $3.91 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $4.38B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Sivik Global Healthcare LLC Portfolio

Follow Sivik Global Healthcare LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sivik Global Healthcare LLC with notifications on news.